SOLID FOSMETPANTOTENATE FORMULATIONS
Solid formulations comprising a compound having formula (I) or a pharmaceutically acceptable salt thereof, and their use in the treatment of neurologic disorders (such as pantothenate kinase-associated neurodegeneration), are provided.
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English |
Published |
23.04.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Solid formulations comprising a compound having formula (I) or a pharmaceutically acceptable salt thereof, and their use in the treatment of neurologic disorders (such as pantothenate kinase-associated neurodegeneration), are provided. |
---|---|
Bibliography: | Application Number: US201816483652 |